AK-5 tumor-induced modulation of host immune function: Upregulation of Th-1-type cytokine response mediates early tumor regression

Cytokines and Molecular Therapy

Volumn 2, Issue 1, 1996, Pages 39-46

  Khar, Ashok ^a   Kausalya, S ^a   Kamal, M A ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Th 1 cytokines; Tumor regression

Indexed keywords

ANTIBODY; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MEMBRANE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; ASCITES; CANCER TRANSPLANTATION; CONTROLLED STUDY; HISTIOCYTOMA; IMMUNOMODULATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTIOCYTOMA, BENIGN FIBROUS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; RATS; RATS, WISTAR; TH1 CELLS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029960222     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Melief CJM, Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res (1992) 58: 143-75.
2. Greenberg PD, Adoptive T-cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol (1991) 49: 281-355.
3. Mosmann TR, Coffman RL, Two types of mouse helper T cell clone: implications for immune regulations. Immunol Today (1987) 8: 223-7.
4. Gajewski TF, Fitch FW, Anti-proliferative effect of IFN-7 in immune regulation. I. IFN-"/ inhibits the proliferation of Th2 but not Thl murine helper T lymphocyte clones. J Immunol (1988) 140: 4245-52.
5. Mosmann TR, Morre KW, The role of IL-10 in cross regulation of Thl and Th2 responses. Immunoparasitol Today (1991) 12: A49-A53.
6. Rosenberg SA, Immunotherapy and gene therapy of cancer. Cancer Res (1991) 51: 5074s-9s.
7. Liu Y, Linsley PS, Costimulation of T cell growth. Curr Opin Immunol (1992) 4: 265-70.
8. Tripp CS, Wolf SE, Unanue ER, Interleukin-12 and tumor necrosis factor-α are co-stimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc NatlAcadSci USA (1993) 90: 3725-9.
9. Anegon I, Cuturi MC, Trinchieri G, Perussia B, Interaction of Fc receptor (CD 16) ligands induces transcription of interleukin-2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med (1988) 167: 452-72.
10. Mule JJ, Shu S, Rosenberg SA, The anti-tumor efficacy of lymphokine-activated killer cell and recombinant IL-2 in vivo. J Immunol (1985) 135: 64652.
11. Fujimoto S, Greene MI, Sehon AH, Regulation of the immune response to tumor antigens, u. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol (1976) 116:800-6.
12. Trinchieri G, Biology of natural killer cells. Adv Immunol (1989) 47: 187-376.
13. Karre K, Hansson M, Kiessling R, Multiple interactions at the natural killer workshop. Immunol Today (1991) 12: 343-5.
14. Kobayashi M, Fitz L, Ryan M et al, Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 170: 82745.
15. Grimm EA, Ramsey KM, Mazumder A et al, Lymphokine activated killer cell phenomenon: II. Precursor phenotype is thymus-derived lymphocytes and natural killer cells. J Exp Med (1983) 157: 884-97.
16. Rosenberg SA, Lotze MT, Muul LM et al, Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. NEnglJMed(l985) 313: 1485-92.
17. Margolin KA, Rayner AA, Hawkins MJ et al, Interleukin-2 and lymphokine activated killer cell therapy of solid tumors: analysis of toxicology and management guidelines. J Clin Oncol (1989) 7: 486-98.
18. Moore MAS, The future of cytokine combination therapy. Cancer (1991) 67: 2718-26.
19. Khar A, Development and characterization of a rat histiocyte-macrophage tumor line. J Natl Cancer lust (1986) 76: 871-8.
20. Khar A, Characterization of spontaneous immunological regression in a histiocytoma: I. Role of NK cells and anti-tumor antibodies. Int J Oncol (1993) 2: 393-8.
21. Khar A, Leela Kumari A, Ali AM, Characterization of spontaneous immunological regression in histiocytoma: II. Participation of tumor necrosis factor. Int J Oncol (1993) 2: 399-402.
22. Kausalya S, Hegde SP, Bright JJ, Khar A, Mechanism of antibody-dependent natural killer cell-mediated AK-5 tumor cell death. Exp Cell Res (1994) 212: 285-90.
23. Kausalya S, Varalakshmi C, Khar A, Correlation of in vitro and in vivo effects of interferon-/ with the spontaneous regression of a rat histiocytoma. J Interferon Cytokine Res (1995) 15: 647-54.
24. Hegde SP, Bright JJ, Kausalya S, Khar A, AK-5 tumor induced expression of IL-12: role of IL-12 in AK-5 regression. Cell Immunol (1995) 162: 241-7.
25. Scott P, Natovitz P, Coffman RL et al, Immunoregulation of cutaneous leishmaniasis: T-cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med (1988) 168: 1675-84.
26. Schneegans ASK, Gaveriaux C, Fonteneau P, Loor F, Indirect double sandwich ELISA for the specific and quantitative measurement of mouse IgM, IgA and IgG subclasses. J Immunol Meth (1989) 119: 117-25.
27. Ijsselmuiden OE, Herbrink P, Meddens MJM et al, Optimizing the solid-phase immunofiltration assay: a rapid alternative to immunoassays. J Immunol Meth (1989) 119: 35-43.
28. Khar A, Varalakshmi CH, Pardhasaradhi BW, Ali AM, Generation of cytotoxic monoclonals against AK-5 histiocytoma: conjugation with daunomycin and use in chemotherapy. Cancer Lett (1992) 64: 163-9.
29. Bright JJ, Hegde SP, Begum Z, Khar A, Modulation of natural killer cell function leading to spontaneous regression of a histiocytoma. Cell Immunol (1994) 154: 54-65.
30. Khar A, Gupta PD, Krishnamurthy D, Studies on AK-5 tumor: further characterization of rat histiocytoma. IndJ Exp Biol (1990) 28: 1101-6.
31. Grimm EA, Robb RJ, Roth JA et al, Lymphokineactivated killer cell phenomenon DI. Evidence that IL2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine activated killer cells. J Exp Med (1983) 158: 1356-61.
32. Trinchieri G, Perussia B, Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Tbrfoy (1985) 6: 131-6.
33. Giovarelli M, Santoni A, Jemma C et al, Obligatory role of IFN-gamma in induction of lymphokine activated and T lymphocyte killer activity but not in boosting of natural cytotoxicity. jf Immunol (1988) 141:2831-6.
34. Peace DJ, Kern DE, Schultz KR et al, IL-4 induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. J Immunol (1988) 140: 3679-85.
35. Hasday JD, Shah EM, Lieberman AP, Macrophage tumor necrosis factor-α release is induced by contact with some tumors. J Immunol (1990) 145: 371-9.
36. Blackwill F, Osborne R, Burke F et al, Evidence for tumor necrosis factor/cachectin production in cancer. Lancet (1990) ii: 1229-32.
37. Stolfi VM, Milsom JW, Finke JH et al, Resident research award: tumor necrosis factor-α selectively enhances growth and cytotoxic activity of tumor infiltrating lymphocytes from human colorectal cancer, jf Surg Res (1992) 52: 39-45.
38. D'Andréa A, Rengaraju M, Valiante NM et al, Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells, jf Exp Med (1992) 176: 1387-98.
39. Boom WH, Liano D, Abbas AK, Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin-4 and interleukin-2 producing T cell clones on resting B lymphocytes. jf Exp Med (1988) 167: 1352-63.
40. Trinchieri G, Interleukin-12 and its role in the generation of Thl cells. Immunol Today (1993) 14: 3358.
41. Swain SL, Weinberg AD, English M, Huston G, IL-4 directs the development ofTh2-like helper effectors, yimmunol (1994) 145: 3796-806.
42. Manetti R, Parronchi P, Guidizi MG et al, Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4 producing Th cells. J ExpMed(l993) 177: 1199-1204.
43. Firestone GS, Roeder WD, Laxer JA et al, A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immimol ( 1989) 143: 518-25.